| Literature DB >> 33484943 |
Cameron MacDonald1, Samuel Ministero1, Manu Pandey2, Denisha Robinson1, Evan Forti Hong1, Bonnie Hylander1, Philip McCarthy2, Christopher Gordon3, Elizabeth Repasky4, Hemn Mohammadpour5.
Abstract
Myeloid derived suppressor cells (MDSCs) are a diverse collection of immune cells that suppress anti-tumor immune responses. Decreasing MDSCs accumulation in the tumor microenvironment could improve the anti-tumor immune response and improve immunotherapy. Here, we examine the impact of physiologically relevant thermal treatments on the accumulation of MDSCs in tumors in mice. We found that different temperature-based protocols, including 1) weekly whole-body hyperthermia, 2) housing mice at their thermoneutral temperature (TT, ~30 °C), and 3) housing mice at a subthermoneutral temperature (ST,~22 °C) while providing a localized heat source, each resulted in a reduction in MDSC accumulation and improved tumor growth control compared to control mice housed at ST, which is the standard, mandated housing temperature for laboratory mice. Additionally, we found that low dose β-adrenergic receptor blocker (propranolol) therapy reduced MDSC accumulation and improved tumor growth control to a similar degree as the models that relieved cold stress. These results show that thermal treatments can decrease MDSC accumulation and tumor growth comparable to propranolol therapy.Entities:
Keywords: Hyperthermia; Myeloid derived suppressor cells; Thermal stress; β-Adrenergic receptor blockers; β-Adrenergic signaling
Mesh:
Substances:
Year: 2021 PMID: 33484943 PMCID: PMC7883813 DOI: 10.1016/j.cellimm.2021.104285
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.178